Plantar fasciitis: the first step out of bed, and the scan that does not track how you feel
The first few steps out of bed are the diagnosis. Sharp pain under the heel, worst on the first stride of the morning, easing after a few minutes of walking, then returning after you have been sitting a while. Nobody with this condition has to be asked twice whether that describes them.
The mechanism behind that pattern is simple. The plantar fascia is a thick band running from the heel bone to the base of the toes, holding up the arch. Overnight your foot rests pointed slightly downward and the band settles short. The first step stretches it abruptly, and the stretch pulls on the damaged tissue at the heel. Walking warms it and it stops complaining. Sitting lets it settle short again, and the next few steps repeat the morning.
Two things people are told that are not true
It is not inflammation. The "-itis" in plantar fasciitis is a historical mistake, the same one that mislabelled tendon problems for a century. What is found in the tissue is degeneration and disorganised repair, not inflammatory cells. Some clinicians now say plantar fasciopathy for exactly this reason. It matters because it explains why anti-inflammatory tablets do less than people expect.
The heel spur is not the problem. A bony spur on the heel turns up on a large share of X-rays in people with this pain — and on a large share in people with no pain at all. It is a consequence of long-term pull on the bone, not the thing pressing into your foot.
The scan does not track how you feel, and there is now a study saying so
A 2026 study measured pain, foot function and quality of life alongside the thickness of the plantar fascia on ultrasound, before and three months after shockwave treatment. The results moved apart.
People got better while the thickness on the scan barely changed. The authors are careful — no control group, so no causal claim — but the observation stands on its own: the band's measured thickness is not a readout of how the foot feels. If you improve and the follow-up scan looks the same, that is not a treatment failure, and if the scan improves and the foot still hurts, that is not a reason to keep going.
What predicts a bad outcome is not what most people expect
A 2025 study looked for the factors that predict who stays in pain with chronic plantar heel pain. What came out on top was not weight, not arch height, not how long the pain had lasted. It was what people believed about their pain, and whether the pain had nerve-like features — burning, tingling, shooting.
In the full model, nothing else was significantly associated with pain.
Two practical consequences. First, if your heel pain burns or shoots rather than aching sharply, that is a signal worth naming to a clinician, because it points somewhere other than a straightforward fascia problem — a compressed nerve in the foot can imitate this closely. Second, catastrophic beliefs about the pain are a treatable target, and treating them is not a suggestion that the pain is imaginary. It is a finding about what predicts the next six months.
The treatment order that the evidence supports
Start with the least invasive things that work and escalate only if they fail. That is not a platitude — it is the explicit conclusion of a 2025 framework that sorted thirty treatments into stages.
Surgery sits at the end of that sequence and reaches very few people.
For the injections and devices in the middle of it, a 2026 network analysis compared them against each other and produced a genuinely useful split.
Read that carefully, because it is a timing argument rather than a winner. Steroid gives the biggest early gain in function. Platelet-rich plasma is where the longer-term improvement is. And shockwave was the one treatment that performed across all measures and all timepoints rather than winning one and fading.
If you are choosing, the question is which of those shapes fits your problem: an early gain that may not hold, a slower one that does, or a broad and moderate one.
Things with weaker support than their popularity suggests
Acupuncture. A comparative analysis found the confidence interval for the net effect of all treatments crossed the line of no effect.
The authors still position it as a reasonable second-line option alongside the others. That is a fair reading of a null result in a small literature — not evidence it works, and not evidence it does not.
Taping and iontophoresis. A 2026 review of eight studies published between 1997 and 2018 concluded both are viable options for reducing pain, at a moderate level of evidence.
Viable and moderate is an honest description. These are cheap and low-risk, which is why they sit early in the sequence, not because they outperform anything.
Ten people with morning heel pain
Ten people wake with sharp pain on the first step. Most have a spur on X-ray if anyone looks, and so do many people with no pain at all. If they are scanned before and after treatment, the thickness on the scan will move less than how they feel — so judging progress by the picture will mislead them in both directions. Of the ten, the ones whose pain burns or shoots, and the ones most frightened by it, are the likeliest to still be in pain months later, and those are the two factors that showed up when everything else was controlled for. Most will improve on the low-risk end of the sequence. A minority reach injections, where the choice is early gain versus durable gain. Almost none reach surgery.
A transferred argument is not evidence
No repair peptide has randomised human trial evidence in plantar fasciitis or plantar heel pain. The condition sits in the same tissue category as tendon problems, so the mechanism argument people make is a transfer from that literature rather than a finding in this one — and a transferred argument is not evidence. Where such a case exists it belongs on a page naming both the compound and this condition, with its tier stated. The operator of this site has a commercial interest in compounds of that kind, which is why this page names the absence and the transfer rather than leaning on either.
Working up the sequence, not down it
- Confirm the pattern. Worst on the first steps of the morning, eases with walking, returns after sitting. Constant pain that does not follow that rhythm is a different problem.
- Stop chasing the spur. It appears in people with no symptoms; it is a consequence, not the cause.
- Deal with the overnight position. The band settling short while you sleep is what makes the first step hurt, which is the specific thing a night splint or a morning stretch before standing addresses.
- Notice whether it burns. Burning or shooting rather than sharp aching predicts a worse course and points toward a nerve, which is a different investigation.
- Work up the sequence, not down it. Low-risk first; injections and procedures only when those fail.
- If you get to an injection, choose on timing. Steroid for the largest early gain in function, platelet-rich plasma for the longer-term improvement, shockwave for consistent moderate benefit across the board.
- Judge by the foot, not the scan. Thickness on ultrasound moved very little in people who got substantially better.
Ask this article · 2 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.